Skip to content

Hong Kong initiates joint research project investigating the lasting impacts of shingles vaccine administration

Clinical trial study, conducted by the University of Hong Kong's clinical trial institute in collaboration with pharmaceutical giant GlaxoSmithKline, aims to explore the possibility of preventing heart disease and dementia.

Hong Kong initiates joint research project exploring long-term implications of shingles vaccination
Hong Kong initiates joint research project exploring long-term implications of shingles vaccination

Hong Kong initiates joint research project investigating the lasting impacts of shingles vaccine administration

In a significant stride towards understanding the long-term implications of vaccinations, the Greater Bay Area International Clinical Trial Institute, in collaboration with the Medical Faculty of the University of Hong Kong and pharmaceutical companies Sinovac Biotech and GlaxoSmithKline (GSK), is embarking on a groundbreaking study. This real-time research aims to investigate the long-term health effects of the shingles vaccine.

Professor Ian Wong Chi-kei, from HKU's department of pharmacology and pharmacy, is leading the study. According to Professor Wong, preliminary data and animal studies suggest that the shingles vaccine may not only protect against the immediate effects of the disease but also potentially prevent long-term health issues such as cardiovascular problems and dementia.

The study will be conducted in real-world settings, providing crucial information for shingles vaccination strategies in the future. It aims to determine the optimal dosage of the vaccine, identify the best time for vaccination, and confirm the long-term effects of the shingles vaccine.

Shingles, an infectious disease that causes a painful, belt-like skin rash with blisters, is a concern for one in three adults in Hong Kong, according to a survey conducted by local medical societies. As of now, health authorities do not track the incidence of shingles in the region.

The collaboration was marked by a memorandum of understanding signed on Tuesday. The study's findings could potentially impact the prevention of long-term health issues associated with shingles, offering hope for a healthier future for many.

As the study progresses, more information about the long-term benefits of the shingles vaccine will be uncovered, shedding light on its potential role in disease prevention beyond its immediate effects. The study's results are eagerly awaited, as they promise to contribute significantly to our understanding of vaccines and their long-term impact on human health.

Read also:

Latest